Prostate cancer with histone modifier UTX mutations can benefit from olaparib

被引：0
|
作者：
Muramoto, N. [1 ]
Iwasaki, M. [2 ]
Sera, Y. [2 ]
Ide, H. [1 ]
Horie, S. [1 ]
Honda, H. [2 ]
机构：
[1] Juntendo Univ, Urol, Grad Sch Med, Bunkyo ku, Tokyo, Japan
[2] Tokyo Womens Med Univ, Inst Lab Anim, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.397
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
271P
引用
收藏
页码：S1578 / S1579
页数：2
相关论文
共 50 条
  • [1] Pancreatic cancer patients with germline BRCA mutations can benefit from olaparib treatment
    Mukherjee, Shibani
    Asaithamby, Aroumougame
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2154 - 2156
  • [2] COMPARATIVE BENEFIT OF OLAPARIB IN RECURRENT BRCAM OVARIAN, BREAST, PANCREATIC AND PROSTATE CANCER
    Peters, P.
    Manrriquez, E.
    Amanam, I.
    Chan, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A47 - A47
  • [3] Elucidation of the pathogenesis of prostate cancer harboring mutations of UTX using genetically engineered mice
    Muramoto, Nobuhito
    Iwasaki, Masayuki
    Ide, Hisamitsu
    Mukai, Shoichiro
    Fukushima, Tsuyoshi
    Horie, Shigeo
    Honda, Hiroaki
    CANCER SCIENCE, 2025, 116 : 1364 - 1364
  • [4] Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
    Gijs van Haaften
    Gillian L Dalgliesh
    Helen Davies
    Lina Chen
    Graham Bignell
    Chris Greenman
    Sarah Edkins
    Claire Hardy
    Sarah O'Meara
    Jon Teague
    Adam Butler
    Jonathan Hinton
    Calli Latimer
    Jenny Andrews
    Syd Barthorpe
    Dave Beare
    Gemma Buck
    Peter J Campbell
    Jennifer Cole
    Simon Forbes
    Mingming Jia
    David Jones
    Chai Yin Kok
    Catherine Leroy
    Meng-Lay Lin
    David J McBride
    Mark Maddison
    Simon Maquire
    Kirsten McLay
    Andrew Menzies
    Tatiana Mironenko
    Lee Mulderrig
    Laura Mudie
    Erin Pleasance
    Rebecca Shepherd
    Raffaella Smith
    Lucy Stebbings
    Philip Stephens
    Gurpreet Tang
    Patrick S Tarpey
    Rachel Turner
    Kelly Turrell
    Jennifer Varian
    Sofie West
    Sara Widaa
    Paul Wray
    V Peter Collins
    Koichi Ichimura
    Simon Law
    John Wong
    Nature Genetics, 2009, 41 : 521 - 523
  • [5] Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
    van Haaften, Gijs
    Dalgliesh, Gillian L.
    Davies, Helen
    Chen, Lina
    Bignell, Graham
    Greenman, Chris
    Edkins, Sarah
    Hardy, Claire
    O'Meara, Sarah
    Teague, Jon
    Butler, Adam
    Hinton, Jonathan
    Latimer, Calli
    Andrews, Jenny
    Barthorpe, Syd
    Beare, Dave
    Buck, Gemma
    Campbell, Peter J.
    Cole, Jennifer
    Forbes, Simon
    Jia, Mingming
    Jones, David
    Kok, Chai Yin
    Leroy, Catherine
    Lin, Meng-Lay
    McBride, David J.
    Maddison, Mark
    Maquire, Simon
    Mclay, Kirsten
    Menzies, Andrew
    Mironenko, Tatiana
    Mulderrig, Lee
    Mudie, Laura
    Pleasance, Erin
    Shepherd, Rebecca
    Smith, Raffaella
    Stebbings, Lucy
    Stephens, Philip
    Tang, Gurpreet
    Tarpey, Patrick S.
    Turner, Rachel
    Turrell, Kelly
    Varian, Jennifer
    West, Sofie
    Widaa, Sara
    Wray, Paul
    Collins, V. Peter
    Ichimura, Koichi
    Law, Simon
    Wong, John
    NATURE GENETICS, 2009, 41 (05) : 521 - 523
  • [6] Elucidation of the pathogenesis of prostate cancer harboring mutations of epigenetic factor UTX using genetically engineered mice
    Muramoto, Nobuhito
    Iwasaki, Masayuki
    Sera, Yasuyuki
    Ide, Hisamitsu
    Mukai, Shoichiro
    Fukushima, Tsuyoshi
    Horie, Shigeo
    Honda, Hiroaki
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Ovarian Cancer: Even Patients with New Infection benefit from Olaparib
    Lichert, Frank
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (04) : 322 - 323
  • [8] Prostate cancer screening research can benefit from network medicine: an emerging awareness
    Valeria Panebianco
    Martina Pecoraro
    Giulia Fiscon
    Paola Paci
    Lorenzo Farina
    Carlo Catalano
    npj Systems Biology and Applications, 6
  • [9] Prostate cancer screening research can benefit from network medicine: an emerging awareness
    Panebianco, Valeria
    Pecoraro, Martina
    Fiscon, Giulia
    Paci, Paola
    Farina, Lorenzo
    Catalano, Carlo
    NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2020, 6 (01)
  • [10] Prognostic Role of DNA Damage Response Genes Mutations and their Association With the Sensitivity of Olaparib in Prostate Cancer Patients
    Zhang, Dong
    Xu, Xinchi
    Wei, Yuang
    Chen, Xinglin
    Li, Guangyao
    Lu, Zhongwen
    Zhang, Xu
    Ren, Xiaohan
    Wang, Shangqian
    Qin, Chao
    CANCER CONTROL, 2022, 29
12345